Get started
Author

Kimberly S. Strickland

Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer
2017 · Giovanna Rossi, Zhaomei Mu, et al. · Clinical Cancer Research · 161
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ
2024 · E. Shelley Hwang, Terry Hyslop, et al. · JAMA · 87
PDF
Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer
2021 · Lorenzo Gerratana, Andrew A. Davis, et al. · JCO Precision Oncology · 54
PDF
Caloric restriction counteracts chemotherapy-induced inflammation and increases response to therapy in a triple negative breast cancer model
2018 · Brittany A. Simone, Ajay Palagani, et al. · Cell Cycle · 45
PDF
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ
2024 · Ann H. Partridge, Terry Hyslop, et al. · JAMA Oncology · 17
PDF
Median and Ulnar Neuropathies in University Pianists
2006 · Abigail P Gohl, Sydney Z Clayton, et al. · Medical Problems of Performing Artists · 8
Abstract P3-01-19: HER2-positive circulating tumor cells (CTCs) in advanced breast cancer (BC): A feature independent of BC subtype
2019 · AN Shah, L Gerratana, et al. · Cancer Research · 2
Spinal cord injured women’s treatment of breast carcinoma: alert to complications
2018 · Ashley L. de Padua, Kimberly Strickland, et al. · Spinal Cord Series and Cases · 2
A Case of Carcinocythemia: De Novo Hormone Receptor-positive Metastatic Breast Cancer Presenting With Circulating Tumor Cells Mimicking an Acute Leukemia
2017 · Roberto S. Fratamico, Kimberly S. Strickland, et al. · Clinical Breast Cancer · 1
The design and implementation of caloric restriction for oncology research (CaReFOR): Is starving cancer cells in the clinical realm feasible?
2017 · Brittany A. Simone, Pramila Rani Anne, et al. · Hematology & Medical Oncology · 1
PDF
Abstract PO5-20-02: Secondary BRain metastases prevention after Isolated intracranial progression on trastuzumab/pertuzumab or T-DM1 in pts with aDvanced human epidermal Growth factor receptor 2+ brEast cancer with addition of Tucatinib (BRIDGET)
2024 · Sarah Sammons, Amanda Van Swearingen, et al. · Cancer Research
Tips-19 Trial in Progress: Secondary Brain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/pertuzumab or T-dm1 in Patients With Advanced Human Epidermal Growth Factor Receptor 2+ Breast Cancer With the Addition of Tucatinib (bridget)
2023 · Amanda Van Swearingen, Sarah Sammons, et al. · Neuro-Oncology Advances
PDF
Abstract CT055: PAVO: A phase-II, open label, single arm study of niraparib in patients with locally advanced/metastatic PALB2 mutated tumors
2023 · Tian Zhang, Thomas Weart, et al. · Cancer Research
Supplementary Table S1. from Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer
2023 · Giovanna Rossi, Zhaomei Mu, et al.
Supplementary Table S2. from Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer
2023 · Giovanna Rossi, Zhaomei Mu, et al.
Supplementary Table S3. from Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer
2023 · Giovanna Rossi, Zhaomei Mu, et al.
PDF
Data from Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer
2023 · Giovanna Rossi, Zhaomei Mu, et al.
Data from Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer
2023 · Giovanna Rossi, Zhaomei Mu, et al.
Supplementary Table S1. from Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer
2023 · Giovanna Rossi, Zhaomei Mu, et al.
PDF
Supplementary Table S2. from Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer
2023 · Giovanna Rossi, Zhaomei Mu, et al.
PDF
Supplementary Table S3. from Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer
2023 · Giovanna Rossi, Zhaomei Mu, et al.
Abstract P5-17-02: Dissecting the biology of inflammatory breast cancer (BC) through cell free DNA and a circulating tumor cells (CTC)-derived signature
2019 · L Gerratana, Q Zhang, et al. · Cancer Research
Abstract P5-17-03: How is inflammatory breast cancer (IBC) different? Integration of clinico-pathological features and circulating tumor cells (CTCs)-based biomarkers for disease and prognostic assessment
2019 · L Gerratana, Q Zhang, et al. · Cancer Research
Abstract 2646: The liquid biopsy network in advanced breast cancer (ABC): Benchmarking the prognostic role of circulating tumor DNA (ctDNA) to the goal standard circulating tumor cells (CTCs) enumeration
2018 · Lorenzo Gerratana, Andrew A. Davis, et al. · Cancer Research
Circulating tumor cells enumeration (CTCs) and circulating tumor DNA (ctDNA): Clinical and molecular features of “rapidly progressing” stage IV disease (Stage IVprog).
2018 · Lorenzo Gerratana, Qiang Zhang, et al. · Journal of Clinical Oncology
Works count: 27
Citation count: 378
H-index: 6
I10-index: 5
Year
Topic
Type